Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study | Aplastic Anemia & MDS International Foundation Return to top.

Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study

Journal Title: 
JAMA Oncology
Primary Author: 
Franke GN
Author(s): 
Franke GN, Kubasch AS, Platzbecker U
Original Publication Date: 
Thursday, December 12, 2019
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.